Targeted Lung Denervation

Gerard J. Criner, MD, FACP, FACCP, discusses the AIRFLOW-3 study which  evaluates the efficacy of targeted lung denervation for patients with COPD.

Related Presenters

Gerard Criner, MD, FACP, FACCP.

Gerard Criner, MD, FACP, FACCP

Director, Temple Lung Center

Gerard Criner, MD is an internationally renowned pulmonologist and Temple’s clinical investigator in advanced lung diseases,COPD, pulmonary fibrosis, respiratory failure, and COVID-19. Dr. Criner is a board member for the Global Initiative ...

View full profile